Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 163.06 million shares for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), IRONWOOD PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 5.6%.
- Historical annual values: Fiscal year 2025: 163.06 million shares | Fiscal year 2024: 160.21 million shares | Fiscal year 2023: 156.35 million shares | Fiscal year 2022: 154.03 million shares | Fiscal year 2021: 162.04 million shares | Fiscal year 2020: 160.62 million shares | Fiscal year 2019: 157.54 million shares | Fiscal year 2018: 154.41 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: